Corrigendum to "Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features" [Modern Pathology 33 (2020) 496-513]

Priyadharsini Nagarajan¹, Jin Piao², Jing Ning³, Laura E Noordenbos⁴, Jonathan L Curry⁵, Carlos A Torres-Cabala⁵, A Hafeez Diwan⁶, Doina Ivan⁵, Phyu P Aung⁷, Merrick I Ross⁸, Richard E Royal⁸, Jennifer A Wargo⁸, Wei-Lien Wang⁷, Rashmi Samdani⁷, Alexander J Lazar⁹, Asif Rashid⁷, Michael A Davies¹⁰, Victor G Prieto¹¹, Jeffrey E Gershenwald¹², Michael T Tetzlaff¹³

Affiliations

¹ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: pnagarajan@mdanderson.org.
² Department of Clinical Preventive Medicine, University of Southern California, Los Angeles, California; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.
⁵ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁶ Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
⁷ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁸ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁹ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹⁰ Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹¹ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹² Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹³ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Now with Departments of Pathology and Laboratory Medicine, The University of California, San Francisco, San Francisco, California. Electronic address: michael.tetzlaff@ucsf.edu.

PMID: 40541156
DOI: 10.1016/j.modpat.2025.100819

Published Erratum

Corrigendum to "Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features" [Modern Pathology 33 (2020) 496-513]

Priyadharsini Nagarajan et al. Mod Pathol. 2025 Aug.

. 2025 Aug;38(8):100819.

doi: 10.1016/j.modpat.2025.100819. Epub 2025 Jun 19.

Authors

Affiliations

¹ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: pnagarajan@mdanderson.org.
² Department of Clinical Preventive Medicine, University of Southern California, Los Angeles, California; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.
⁵ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁶ Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
⁷ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁸ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁹ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹⁰ Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹¹ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹² Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
¹³ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Now with Departments of Pathology and Laboratory Medicine, The University of California, San Francisco, San Francisco, California. Electronic address: michael.tetzlaff@ucsf.edu.

PMID: 40541156
DOI: 10.1016/j.modpat.2025.100819

No abstract available

PubMed Disclaimer

Erratum for

Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Nagarajan P, et al. Mod Pathol. 2020 Mar;33(3):496-513. doi: 10.1038/s41379-019-0340-7. Epub 2019 Aug 5. Mod Pathol. 2020. PMID: 31383963

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features" [Modern Pathology 33 (2020) 496-513]

Affiliations

Corrigendum to "Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features" [Modern Pathology 33 (2020) 496-513]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources